Patients with an implantable cardioverter-defibrillator (ICD) require follow-up to monitor their clinical status and device function. Remote home monitoring has the potential to reduce costs and ...
SALT LAKE CITY--(BUSINESS WIRE)-- Healthcare reform, new compliance regulations, and the move to outcomes-based payment are putting pressure on clinical documentation and coding processes at hospitals ...
Please provide your email address to receive an email when new articles are posted on . The FDA approved an extravascular ICD system to treat tachycardia that may cause sudden cardiac arrest. Placing ...
Dr Melissa Walton-Shirley brings a personal and practice-focused perspective to headlines, research, and overlooked cardiology gems.
Abbott announced that the FDA approved its next-generation Bluetooth-capable implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator devices. The devices (Gallant, ...
Hosted on MSN
AtaCor raises $75m for trial of EV-ICD system
AtaCor Medical has announced up to $75m in financing to support a pivotal study of its extravascular implantable cardioverter-defibrillator (EV-ICD) system. The US Food and Drug Administration (FDA) ...
The novel design of AtaCor's Atala™ lead aims to provide reliable sensing, antitachycardia pacing (ATP), and shock therapies with no hardware placed in the heart or vasculature SAN CLEMENTE, Calif., ...
CHICAGO (Reuters) - A cardiologists group called for closer monitoring of the performance of wire leads that connect implanted defibrillators and pacemakers to the heart in the wake of malfunctions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback